Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. (Q53099318)

11 May 2018

title

Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. (English)

1 reference

11 May 2018

author

Demetrio Milardi

7

1 reference

11 May 2018

Paolo Ruggeri

object named as

Paolo Ruggeri

3

0 references

Carmelo Rodolico

object named as

Carmelo Rodolico

5

0 references

author name string

Michele Gaeta

1

1 reference

11 May 2018

Emanuele Barca

2

1 reference

11 May 2018

Fabio Minutoli

4

1 reference

11 May 2018

Silvio Mazziotti

6

1 reference

11 May 2018

Olimpia Musumeci

8

1 reference

11 May 2018

Antonio Toscano

9

1 reference

11 May 2018

publication date

9 July 2013

1 reference

11 May 2018

Molecular Genetics and Metabolism

published in

1 reference

11 May 2018

volume

110

1 reference

11 May 2018

page(s)

290-296

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

1 reference

Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Neuromuscular imaging in inherited muscle diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

A 46-year-old man with dyspnea and left diaphragm paralysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Adult-onset acid maltase deficiency. Case report of an adult with severe respiratory difficulty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Standardisation of spirometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

ATS/ERS Statement on respiratory muscle testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Predicted normal values for maximal respiratory pressures in caucasian adults and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Prevention of pulmonary morbidity for patients with neuromuscular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Volume rendering based on magnetic resonance imaging: advances in understanding the three-dimensional anatomy of the human knee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification--a feasibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Aging of the diaphragm: a CT study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Computed tomography of the diaphragm: normal anatomy and variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Variation in diaphragm position and shape in adults with normal pulmonary function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Imaging of the diaphragm: anatomy and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Neural deficits contribute to respiratory insufficiency in Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Supine volume drop and diaphragmatic function in adults with Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Hypoglossal neuropathology and respiratory activity in pompe mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Respiratory muscle fibres: specialisation and plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1-2 October 2009, Paris, France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.06.023

10.1016/J.YMGME.2013.06.023

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

23916420

1 reference

11 May 2018